Own stem cells tried for rare nerve disease
NCT ID NCT04825626
First seen Oct 01, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tests the safety and early effects of using a patient's own stored stem cells to treat chronic inflammatory demyelinating polyneuropathy (CIDP), a rare nerve disorder. Only one patient who has banked their stem cells at the sponsor's facility can join. The treatment involves multiple infusions over 44 weeks, with follow-up for about a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.